Livzon Pharmaceutical Group Inc (000513) - Total Liabilities

Latest as of September 2025: CN¥9.17 Billion CNY ≈ $1.34 Billion USD

Based on the latest financial reports, Livzon Pharmaceutical Group Inc (000513) has total liabilities worth CN¥9.17 Billion CNY (≈ $1.34 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Livzon Pharmaceutical Group Inc to assess how effectively this company generates cash.

Livzon Pharmaceutical Group Inc - Total Liabilities Trend (1992–2024)

This chart illustrates how Livzon Pharmaceutical Group Inc's total liabilities have evolved over time, based on quarterly financial data. Check 000513 financial resilience to evaluate the company's liquid asset resilience ratio.

Livzon Pharmaceutical Group Inc Competitors by Total Liabilities

The table below lists competitors of Livzon Pharmaceutical Group Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Tidewater Inc NYSE:TDW	USA	$989.86 Million
Genting Malaysia Bhd KLSE:4715	Malaysia	RM19.44 Billion
Lotus Health Group Co SHG:600186	China	CN¥1.54 Billion
Viscofan MC:VIS	Spain	€504.10 Million
Shanghai Yuyuan Tourist Mart Co Ltd SHG:600655	China	CN¥82.56 Billion
Axcelis Technologies Inc NASDAQ:ACLS	USA	$331.80 Million
Vista Energy S.A.B. de C.V. BA:VIST	Argentina	AR$1.40 Billion
Shenzhen China Micro Semicon Co. Ltd. A SHG:688380	China	CN¥304.00 Million

Liability Composition Analysis (1992–2024)

This chart breaks down Livzon Pharmaceutical Group Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 000513 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.25	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.66	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.37	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Livzon Pharmaceutical Group Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Livzon Pharmaceutical Group Inc (1992–2024)

The table below shows the annual total liabilities of Livzon Pharmaceutical Group Inc from 1992 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥9.55 Billion ≈ $1.40 Billion	-7.08%
2023-12-31	CN¥10.28 Billion ≈ $1.50 Billion	+3.52%
2022-12-31	CN¥9.93 Billion ≈ $1.45 Billion	+23.17%
2021-12-31	CN¥8.06 Billion ≈ $1.18 Billion	+15.97%
2020-12-31	CN¥6.95 Billion ≈ $1.02 Billion	+21.92%
2019-12-31	CN¥5.70 Billion ≈ $834.27 Million	+0.24%
2018-12-31	CN¥5.69 Billion ≈ $832.26 Million	+21.94%
2017-12-31	CN¥4.66 Billion ≈ $682.51 Million	+36.23%
2016-12-31	CN¥3.42 Billion ≈ $500.98 Million	+4.77%
2015-12-31	CN¥3.27 Billion ≈ $478.16 Million	+1.47%
2014-12-31	CN¥3.22 Billion ≈ $471.21 Million	+8.74%
2013-12-31	CN¥2.96 Billion ≈ $433.36 Million	+20.70%
2012-12-31	CN¥2.45 Billion ≈ $359.04 Million	+54.19%
2011-12-31	CN¥1.59 Billion ≈ $232.86 Million	+55.58%
2010-12-31	CN¥1.02 Billion ≈ $149.67 Million	+13.79%
2009-12-31	CN¥898.92 Million ≈ $131.54 Million	-17.48%
2008-12-31	CN¥1.09 Billion ≈ $159.40 Million	+14.09%
2007-12-31	CN¥954.80 Million ≈ $139.72 Million	-11.58%
2006-12-31	CN¥1.08 Billion ≈ $158.02 Million	+16.72%
2005-12-31	CN¥925.20 Million ≈ $135.39 Million	-10.17%
2004-12-31	CN¥1.03 Billion ≈ $150.72 Million	+7.88%
2003-12-31	CN¥954.70 Million ≈ $139.70 Million	+31.31%
2002-12-31	CN¥727.05 Million ≈ $106.39 Million	+13.71%
2001-12-31	CN¥639.37 Million ≈ $93.56 Million	+10.00%
2000-12-31	CN¥581.24 Million ≈ $85.05 Million	-0.46%
1999-12-31	CN¥583.95 Million ≈ $85.45 Million	+18.09%
1998-12-31	CN¥494.51 Million ≈ $72.36 Million	+4.45%
1997-12-31	CN¥473.43 Million ≈ $69.28 Million	-13.46%
1996-12-31	CN¥547.10 Million ≈ $80.06 Million	+22.26%
1995-12-31	CN¥447.49 Million ≈ $65.48 Million	+81.43%
1994-12-31	CN¥246.65 Million ≈ $36.09 Million	-1.58%
1993-12-31	CN¥250.60 Million ≈ $36.67 Million	-21.37%
1992-12-31	CN¥318.71 Million ≈ $46.64 Million	--

About Livzon Pharmaceutical Group Inc

SHE:000513 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.81 Billion

CN¥19.20 Billion CNY

Market Cap Rank

#5139 Global

#996 in China

Share Price

CN¥32.65

Change (1 day)

-0.55%

52-Week Range

CN¥32.54 - CN¥43.90

All Time High

CN¥1418.81